Post Profile

Related Posts

BOUTIQUE BLOWOUT: 3 tiny firms will make a killing on a $14 billion pharma deal

Business & Finance : Business Insider: Clusterstock

Pfizer is buying the cancer drugmaker Medivation for $14 billion and three small banks helped make it happen. Guggenheim Securities and Centerview Partners advised Pfizer on the deal, while JPMorgan and Evercore advised Medivation. ...

Are Big Pharma Mergers Good for New Drugs?

Business & Finance : Business: The Atlantic

Merck and Schering-Plough, Wyeth and Pfizer...well, OK, everybody and Pfizer. There have been plenty of big mergers over the last few years in the drug industry, and they've always been accompanied by talk of economies of scale, cri...

Big Pharma Is So 2015. Welcome to the Era of Big Software

Business & Finance : Wired: Business

Google, Amazon, Apple, and Facebook could dominate the tech market in the same way Pfizer and Kellogg's dominated food and pharma. The post Big Pharma Is So 2015. Welcome to the Era of Big Software appeared first on WIRED.

Big Pharma's Pfizer And Merck To Feel Pinch Of Strong Dollar, Patent Loss

Business & Finance : Forbes: Business

Strong dollar headwinds are likely to smack pharmaceutical giants Pfizer Inc. (PFE) and Merck & Co. (MRK) when they report earnings Tuesday ahead of the market’s opening. Both big pharma firms have a heavy international presence—mor...

From big pharma to really big pharma

Business & Finance : Business Report

The tie-up between Pfizer and Allergan looks set to create a drug-making behemoth with products from Viagra to Botox. ||| New York - Pfizer and Allergan agreed to combine in a record $160 billion deal, creating a drug-making behemot...


Copyright © 2016 Regator, LLC